The autoimmune disorder destroys the body’s ability to produce insulin. Some patients in experimental trials have gotten it ...

SGLT2 inhibitors are a welcome addition to GN care, but the field is still grappling with the gap between molecular ...

The Phase III results impressed Guggenheim Partners analysts both in terms of efficacy and safety. If approved, atacicept ...

Another common feature: Patients with a number of autoimmune diseases, especially women, often suffer heart attacks and ...

It's one of medicine's biggest mysteries — why sometimes our immune system attacks our own bodies. Autoimmune diseases affect as many as 50 million Americans and millions more worldwide.

Results of the Bayer-led Phase 3 FINE-ONE clinical trial, presented at the American Society of Nephrology Kidney Week in ...

Boehringer recently reported positive results from the Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced NSCLC at ESMO 2025. The company is pursuing regulatory ...

In The Alternative Number Ones, I’m reviewing every #1 single in the history of the Billboard Modern Rock Tracks/Alternative Songs, starting with the moment that the chart launched in 1988. This ...

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers and severe pain for six years. She saved her ...

The seven Colorado River states, including New Mexico, failed to reach a broad agreement Tuesday on how to share the river’s ...

Izzy was a brilliant baby, quite content and happy. She was my second, so I was absolutely delighted, as my son, Ben, had been a screamer. The first sign of anything amiss was a public-health visit in ...

Hosts David and Gina explore how scientists over the centuries unlocked the ability to edit our genes ...